跳至主要内容
临床试验/IRCT20201102049232N3
IRCT20201102049232N3招募中3 期

The short-term effect of lorazepam on the anxiety level of ST Elevation Myocardial Infarction (STEMI) patients candidate for Primary Percutaneous Coronary Intervention (PPCI)

Qazvin University of Medical Sciences0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • ST Elevation Myocardial Infarction (STEMI) patients candidate for Primary Percutaneous Coronary Intervention (PPCI)

排除标准

  • Patients who cannot take lorazepam because of Drug interactions, including alcohol; barbiturates; antipsychotics sedatives; hypnotics; anxiolytics; opioids; antidepressants; narcotics; analgesics; sedatives; antihistamines; anticonvulsants and anesthetics.
  • Patients who cannot take lorazepam because of lorazepam Contraindications including Allergy to Lorazepam; acute angle; closure glaucoma; severe respiratory depression and sleep apnea
  • Patients who cannot take lorazepam because of unconsciousness

研究者

相似试验

The effect of Lorazepam on the anxiety of heart... | 临床试验